Hepatitis B virus reactivation in a case of Waldenstrom's macroglobulinemia treated with chemotherapy and rituximab despite adefovir prophylaxis

被引:9
作者
Khaled, Yasser [1 ]
Hanbali, Amr [1 ]
机构
[1] Henry Ford Hosp, Dept Internal Med, Div Hematol Oncol, Detroit, MI 48202 USA
关键词
D O I
10.1002/ajh.20861
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:688 / 688
页数:1
相关论文
共 5 条
[1]   Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP [J].
Dai, MS ;
Chao, TY ;
Kao, WY ;
Shyu, RY ;
Liu, TM .
ANNALS OF HEMATOLOGY, 2004, 83 (12) :769-774
[2]   Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations [J].
Law, JK ;
Ho, JK ;
Hoskins, PJ ;
Erb, SR ;
Steinbrecher, UP ;
Yoshida, EM .
LEUKEMIA & LYMPHOMA, 2005, 46 (07) :1085-1089
[3]  
Sarrecchia Cesare, 2005, Journal of Infection and Chemotherapy, V11, P189, DOI 10.1007/s10156-005-0385-z
[4]  
Tsutsumi Yutaka, 2005, Expert Opin Drug Saf, V4, P599, DOI 10.1517/14740338.4.3.599
[5]   Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy - A prospective case series [J].
Vassiliadis, T ;
Garipidou, V ;
Tziomalos, K ;
Perifanis, V ;
Giouleme, O ;
Vakalopoulou, S .
AMERICAN JOURNAL OF HEMATOLOGY, 2005, 80 (03) :197-203